The insurer’s Canadian group benefits business, which works with businesses on supplemental employee health plans, said there has been a 228 per cent spike in hormone replacement therapy claims in the past five years among women in the 45 to 54 age range. (The Logic)

Talking point: Manulife said there has been a shift toward more proactive menopause treatments across age ranges to help workers cope with symptoms like poor sleep and anxiety, citing data from the Menopause Foundation of Canada, which estimates that the economy could see a $3.5-billion boost if more women could stay in the workforce during their peak working years. Businesses are rushing to seize the opportunity. AbCellera’s stock popped last month after it announced a new menopause treatment trial, and telehealth companies like Felix have launched menopause care programs this year, citing the broad potential impact for patients.

Sponsored Content

How to shift your workforce from AI experimentation to adoption

By Jessica Aftimus Rosa

The real-world economic offshoots of sovereign AI

By Deborah Aarts

Increasing healthcare access across Canada

By Deborah Aarts

Paid promotional content